Atlas Trials

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Clinical trial NCT02021500 · COMPLETED

Trial details

NCT number
NCT02021500
Sponsor
Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Pancreatic Cancer
Start date
2014-01-02
Primary completion
2015-04-16
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.